Archive: 07/03/2018

EU medicines agency suspends Zinbryta

The London-based European Medicines Agency announced Wednesday that multiple sclerosis drug Zinbryta has been suspended immediately and recalled due to reports that it sparked brain inflammation.

page 2 from 10